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Maintenance of an intact epithelial barrier constitutes a pivotal defense mechanism
against infections. Staphylococcus aureus is a versatile pathogen that produces multiple
factors including exotoxins that promote tissue alterations. The aim of the present study
is to investigate the cytopathic effect of staphylococcal exotoxins SEA, SEG, SEI, SElM,
SElN and SElO on the cell cycle of various human cell lines. Among all tested exotoxins
only SEIO inhibited the proliferation of a broad panel of human tumor cell lines in vitro.
Evaluation of a LDH release and a DNA fragmentation of host cells exposed to SEIO
revealed that the toxin does not induce necrosis or apoptosis. Analysis of the DNA
content of tumor cells synchronized by serum starvation after exposure to SEIO showed
G0/G1 cell cycle delay. The cell cycle modulating feature of SEIO was confirmed by
the flow cytometry analysis of synchronized cells exposed to supernatants of isogenic
S. aureus strains wherein only supernatant of the SElO producing strain induced G0/G1
phase delay. The results of yeast-two-hybrid analysis indicated that SEIO’s potential
partner is cullin-3, involved in the transition from G1 to S phase. In conclusion, we
provide evidence that SEIO inhibits cell proliferation without inducing cell death, by
delaying host cell entry into the G0/G1 phase of the cell cycle. We speculate that this
unique cell cycle modulating feature allows SEIO producing bacteria to gain advantage
by arresting the cell cycle of target cells as part of a broader invasive strategy.
Keywords: cell cycle alteration, Staphylococcus aureus, enterotoxin O, G0/G1 phase delay, cullin-3, cyclomodulin
INTRODUCTION
A broad spectrum of exotoxins are produced by Staphylococcus aureus that include staphylococcal
enterotoxins (SE) and staphylococcal enterotoxin-like toxins (SEl). SEl designates enterotoxins that
either lack or have not been tested for emetic properties (Lina et al., 2004). Twenty three such
toxins are now recognized designated SE or SEl A to X (Spaulding et al., 2013). These toxins share
superantigenic properties by using very low concentrations to bind to the MHCII receptors and
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activate a large population of T cells via specific vβ regions
of the T-cell receptor (TCR) (Marrack and Kappler, 1990).
Such polyclonal T-cell mitogenesis results in differentiation
into cytotoxic effector cells together with massive secretion
of cytokines such as interleukin-2 (IL)-2, interferon gamma
(IFN-γ), tumor necrosis factor alpha (TNF-α), and nitric oxide
(NO). Several members of this group have been implicated in the
pathogenesis of toxic shock syndrome and food poisoning and
have shown anti-tumor activity in animal models (Terman et al.,
2006).
The most frequently encountered group of SEs are encoded
by the enterotoxin gene cluster (egcSEs), an operon consisting
of five genetically linked SEs, SEG, SEI, SElM, SElN and SElO
and two pseudotoxins (Supplementary Figure S1). These egcSEs
alone or together with classic SEs have been identified in
up to 80% of S. aureus isolates (Jarraud et al., 2001; Becker
et al., 2003). While the egcSEs are structurally homologous and
phylogenetically related to classic SEA-E, each one exhibits a
unique vβ signature (Thomas et al., 2009). egcSEs have been
shown to be transcribed in humans during nasal colonization
(Burian et al., 2012). Notably, bacteremia with S. aureus
strains producing egcSEs is reported to be less severe clinically
than that linked to S. aureus strains producing the classic
SEs (Ferry et al., 2005; van Belkum et al., 2006). Despite
their broad distribution and occurrence, neutralizing antibodies
in human sera directed against the egcSEs are significantly
lower than those specific for the classic SEs (Holtfreter et al.,
2004).
In a recent clinical study of patients with advanced non-
small cell lung cancer, a preparation from a partially purified
supernatant from a strain producing only egcSEs induced
objective anti-tumor responses (Ren et al., 2004). In search of
the mechanisms for the tumoricidal activity of the wild type
egcSEs, we demonstrated that egcSEs induce potent NO and TH-
1 cytokine dependent tumor killing of a panel of human tumor
cells comparable to canonical SEA (Terman et al., 2013).
Superantigens use several mechanisms to induce tumor cell
cytotoxicity in vitro and in vivo. In superantigen dependent
cellular cytotoxicity (SDCC) SAgs efficiently bind MHC class
II-positive tumor cells which then initiate human T cell
proliferation and differentiation into cytotoxic T cells that
lyse tumor cells in a perforin/granzyme dependent manner
(Dohlsten et al., 1995). MHCII deficient tumor cells can be
activated by selected superantigens to express CD154 which
costimulates T cell proliferation in a vβ specific manner
(Lamphear et al., 1998). Under such conditions T cell activation
may be augmented by a recently discovered B7 domain present
in selected SEs which interacts with T cell costimulatory
receptor CD28 (Arad et al., 2011). Furthermore, both canonical
and egc SE-activated T cells and monocytes produce various
cytolytic cytokines notably IFN-γ, TNF-α, IL-2 which alone
or together with nitrous oxide can induce cytotoxicity in
both MHCII+ and MHCII- tumor cells (Fast et al., 1991;
Dohlsten et al., 1993). Superantigens have also been shown to
activate epithelial cells to produce a broad array of cytokines
and chemokines (Peterson et al., 2005). Despite extensive
investigation of SAg-cell interactions, classic and egcSEs have
not been shown to exert a direct cytostatic effect on target
cells.
Here, we further examine the interaction of egcSEs with target
tumor cells and unveil a novel property of SEIO, namely the
induction of cytostasis in several human tumor cell lines by S
phase inhibition during cell cycle progression. Such cytostasis
is the result of direct interaction of SEIO with the target
cells independent of T cells or TH-1 cytokines. Deploying
double hybrid analysis we have also identified cullin-3, a E3
ubiquitin ligase involved in transition from G1 to S phase, as
the putative target of SElO. This cell cycle modulating feature
constitutes a new cytopathic mechanism by which SEIO alone
or together with other SEs can disable host anti-microbial
defenses.
MATERIALS AND METHODS
Preparation of Recombinant SEs
SEA, SEG, SEI, SElM, SElN, and SElO were produced in RN6390
S. aureus strain transformed with pLUG345 (Boisset et al., 2007)
as His-tagged recombinant toxins as previously described for
SEA, SEG, SEI, SElM, and SElO (Thomas et al., 2009). We
deployed the same strategy to produce SElN using the couple
of primers (GAAGGCCTAG ATTGTTCTAC ATAGCTGCAA
TTATAATAAC with the addition of a StuI restriction site
(underlined) and CCGCGGATCCG TTATTAATGA TGAT
GATGAT GATGAGAACC CCCATCTTTA TATAAAAATA
CATCAATATG ATAATTAG with the addition of a BamHI
restriction site) (Thomas et al., 2009). His-tagged recombinant
toxins were purified by affinity chromatography on a nickel
affinity column according to the supplier’s instructions (New
England Biolabs, Ipswich, MA, USA). Protein purity was verified
by SDS-PAGE. LPS was removed from toxin solutions by affinity
chromatography with Detoxi-GEL endotoxin Gel
R©
(Pierce,
Rockford, IL, USA). The QCL-1000 Limulus amebocyte lysate
assay
R©
(Cambrex-BioWhittaker, Walkersville, MD, USA) showed
that the endotoxin content of the recombinant SSAg solutions
was less than 0.005 units/mL. Toxins activities were assessed
by measuring CD69 surface expression by T cells upon toxin
challenge (data not shown).
Human Tumor Cell Lines
Laryngeal squamous cell carcinoma cell line Hep-2 and human
non-small cell lung adenocarcinoma CRL5800 were obtained
from cell library (IFR128, Lyon, France). Osteogenic sarcoma
CRL1547, human breast cancer cell line MDA-MB-549, human
neuroblastoma cell line SK-N-BE and human melanoma PLA-
OD were a gift from Raphael Rousseau (Centre Leon Berard,
Lyon, France). The human cervix cancer HeLa cells were
obtained from American Type Culture Collection, Manassas,
VA, USA. Cell lines were cultured in Dulbecco’s modified
Eagle medium (DMEM) (Gibco, Invitrogen Corporation, Cergy
Pontoise, France) supplemented with 10% fetal calf serum (FCS)
(BioWest, Paris, France), 100 U/mL penicillin and 100 µg/mL
streptomycin.
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Cytotoxicity Assays
MTT and [3H]TdR Assays
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) cytotoxic assay and [3H]TdR assay were performed to
investigate the effect of SEs on cell viability (Hmama et al.,
1993; Terman et al., 2013). Tumor cells (105 cells/well) were
seeded in 96-well plates and incubated during 48 h with
different concentration of toxin (0, 1, 10, 15 µg/mL) or cisplatin
(3 µg/mL) as positive control. For MTT assay, 10 µL of MTT
solution (5 mg/mL) (Invitrogen Corporation, Cergy Pontoise,
France) was added to culture wells and plates were incubated
for 3 h at 37◦C. Supernatant was removed and 100 µL of 0.04 N
HCl in isopropanol was added to each well before reading optical
density at 540 nm (OD540) with an ELISA-Reader (Bio-Rad,
Marne la Coquette, France).
Cell viability data are expressed as ratio of OD540 of treated
cells /untreated cells.
For [3H]TdR assay, 5 µ Ci of [3H]TdR (1Ci/mM, CEA,
Sacaly, France) was added during 48h to each well. After three
washes with phosphate buffered saline (PBS) without Ca2+ and
Mg2+, cells were collected on glass fibber filters and [3H]TdR
incorporation was measured in Beckman scintillation counter.
Cell viability data are expressed as the percentage of the mean
value obtained for untreated cells.
Lactate Dehydrogenase (LDH) Release
Tumor cells (105 cells/well) were seeded in 96-well plates
and incubated for 48 h with various concentrations of
toxin (0, 1, 15 µg/mL). LDH release by tumor cells
was assessed by Lactate Dehydrogenase assay on the
ARCHITECT SystemsTM (Abbott). The nominal range
of this assay is 30–2000 U/mL. Maximum LDH value
was determined by addition of 10 X lysis solution (9%
Tritron X-100 vol/vol) and percentage of cytotoxicity
was calculated using the following formula: percent
cytotoxicity = (value from test well – value from untreated
well)/(value from the maximum – value from untreated well) X
100.
DNA Fragmentation Assays
DNA fragmentation of tumor cells was detected by the
terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) method implemented with the In Situ Cell Death
Detection Kit TMR-red (Roche applied-science), according
to the manufacturer’s instructions. Briefly, tumor cells (105
cells/well) were seeded in Lab-Tek for 48 h with toxins (0, 1,
10, 25 µg/mL) or staurosporine (1 µM) as positive control.
After three washes with PBS without Ca2+ and Mg2+, cells
were fixed with paraformaldehyde (4%) during 30 min at
room temperature, washed twice and rendered permeable by a
solution of sodium citrate and triton X-100 (0.1%) at +4◦C.
Labeling reaction was carried out with at 37◦C for 1 h
terminal deoxynucleotidyl transferase, dUTP-rhodamine. Cells
were washed twice and seeded before analysis by fluorescence
microscopy with Zeiss Axiovert 135 with Axiocam camera (Zeiss,
France).
Cells Synchronization and Cell Cycle Analysis
Two synchronization protocols were used in the present study.
The serum starvataion method arrests the cells in the G0/G1
phase, while the double-thymidine block arrests the cells at the
G1/S border (Nougayrède et al., 2005). For cell synchronization
by serum depletion Hep-2 cells were grown in a 25-ml flask
up to 30% confluence. After washing with PBS, the cells were
incubated for 48 h in DMEM supplemented with 0.5% FCS at
37◦C with 5% CO2 before been cultured for 48 h in the presence
or absence of 25 µg/ml of SElO with DMEM supplemented with
5% FCS at 37◦C with 5% CO2. Cells were them detached by
trypsin-ethylenediaminetetraacetic acid (EDTA) (Gibco), washed
by PBS and fixed in 70% ethanol 2 h at +4◦C. Cells were then
washed with PBS, stained with propidium iodide (PI) in presence
of 1 mg/mL of RNAse (Sigma) and were analyzed by the flow
cytometery (Becton Dickinson, Le Pont de Claix, France) with
Mod-Fit (Verity Software House, USA) and FACSDiva 6.2 (BD
Biosciences) as described (Nougayrède et al., 2005). Data were
collected from 20,000 cells and analysis was performed with
CFlow software.
In order to synchronize the cells at the G1/S border, the
commonly used double thymidine block (DTB) protocol was
employed as described (Deplanche et al., 2015). Briefly, HeLa
cells were grown in a 25-mL flask up to 30% confluence. After
washing with PBS, the cells were cultured in DMEM containing
10% of FCS supplemented with 2 mM thymidine (DMEM-T)
for 18 h. Thymidine was then removed by washing with PBS
and the cells were cultured for 9 h to release cells. The cells
were then cultured in DMEM-T for 17 h, followed by DMEM
containing 10% of FCS. The detached cells were then combined
with adherent cells and fixed in 70% ethanol overnight. Cells
were then stained with PI and analyzed with an Accuri C6
flow cytometer (BectonDickinson, Le Pont de Claix, France)
as described previously (Deplanche et al., 2015). Data were
collected from 20,000 cells, and analysis was performed with
CFlowsoftware (Becton Dickonson).
Preparation of S. aureus Supernatants
Staphylococcus aureus RN6390 pLUG345 (a strain that does
not produce any SE and SEls) and RN6390 pLUG345::selo (a
strain that produces only his-tag SElO) were used to examine
the effect of SElO on cell cycle. Aliquots from overnight
cultures of both S. aureus strains on Brain Heart Infusion
(BHI) broth at 30◦C were diluted (1:50) in DMEM and
incubated at 30◦C for 24 h. The culture supernatants of RN6390
pLUG345 and RN6390 pLUG345::selo strains were collected
after separation of the bacteria by centrifugation and adjusted
to an optical density (λ = 600 nm) of 0.6. The S. aureus
supernatants were concentrated 10-fold using a speed-vac
(SpeedVac Concentrator SVC11 and Refrigerated Condensation
Trap Savant) and pH of the concentrated supernatant was
adjusted to 7.4. The superatants were then sterilized by filtration
through a 0.22-µm filter (Millipore) and stored at −20◦C before
the analysis. The total protein concentrations of the concentrated
supernatants did not differ by more than 10% between
samples.
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Toxins Analysis in S. aureus
Supernatants
Concentrations of Hla, PSM-α1 and PSM-α3 in RN6390
pLUG345 and RN6390 pLUG::selo preparation were determined
by ELISA and HPLC-MS as previously described (Otto et al.,
2013; Deplanche et al., 2015). Quantification of SElO in S. aureus
supernatants was performed using targeted mass spectrometry
analysis. Briefly, strain supernatants (100 µL) were reduced for
45 min at 56◦C with DTT (10 mM final) and alkylated for 45 min
at room temperature in the dark with iodoacetamide (55 mM
final). Urea was added (2 M final) to the supernatants before
digestion using LysC/trypsin mix (Promega, Charbonnières les
Bains, France) at an enzyme/protein ratio of 1/20 (w/w) for 2 h at
37◦C. Samples were diluted with 25 mM ammonium bicarbonate
to reduce urea to 0.2 M final concentration before performing
digestion overnight at 37◦C. [13C6]-lysine labeled peptide
(TVDIYGVYYK, HeavyPeptide AQUA Ultimate, Thermo Fisher
Scientific, Courtaboeuf, France) was added to the digested
samples at a final concentration of 50 pmoles/mL. Then, samples
were desalted on C18 columnTip (Proteabio, Morgantown, WV,
USA) before drying by vacuum centrifugation. Digests were
resolubilized in 40 µL of 2% acetonitrile, 0.1% formic acid
FIGURE 1 | SElO inhibits cell line viability. Hep-2, CRL5800, CRL 1447, MDA-MB-549 SK-N-BE and PLA-OD cell lines (105 cells) were incubated with or without
SEA, SEG, SEI, SElM, SElN, SElO (1–10 µg/mL) or cisplatin (10 µM) as positive control during 48 h. At the end of this incubation period, cell viability was assessed
using the MTT assay. Cell viability data are expressed as 100 X ratio of OD540 of treated cells/untreated cells. Values are mean ±SD (n = 3 independent experiments
for Hep-2, CRL1447 cell lines and one experiment for CRL5800, MDA-MB-549 SK-N-BE and PLA-OD cell lines, each experiment containing 3 replicates).
∗P < 0.05, vs. negative control without toxin.
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and 6 µL were injected on the LC-system. Targeted proteomics
analyses were performed on a 6500 QTrap mass spectrometer
(AB Sciex, Les Ulis, France) operating in the selected reaction
mode (SRM). Liquid chromatography (LC) separation was
performed on an ultimate 3000 system (Dionex, Voisins le
Bretonneux, France) coupled to a Kinetex XB-C18 column
(2.1 × 100 mm, 1.7 µm, 100 Å; Phenomenex, Le Pecq, France).
Peptides were separated using a linear 4–40% acetonitrile
gradient over 35 min at a flow rate of 50 µL/min. Digested
recombinant SElO was used to determine SElO signature
peptides and SRM transitions and to schedule acquisition. SElO
quantification in S. aureus supernatants was derived from the
unlabelled/labeled peak area ratios obtained from 3 transitions of
the TVDIYGVYYK signature peptide.
Exposure of HeLa Cells to Bacterial
Supernatants
Three hours after the DTB release, HeLa cells were exposed
to concentrated S. aureus supernatants for 19 h or 22 h.
Concentrated DMEM was used as a control at the same time
points. The incubation time was chosen in agreement with
the recognized evaluation of the phases of the HeLa cell cycle
and the previous experiments (Deplanche et al., 2015). All the
experiments were performed three times.
Yeast Two-Hybrid Analysis
Yeast two-hybrid screening was performed by Hybrigenics
Services, S.A.S., Paris, France (http://www.hybrigenics-
services.com). The coding sequence for SElO aa 30-261 was
PCR-amplified and cloned into pB27 as a C-terminal fusion to
LexA (N-LexA-SEO-C) and into pB66 as a C-terminal fusion
to Gal4 DNA-binding domain (N-Gal4-SEO-C). The constructs
were checked by sequencing and used as a bait to screen a
random-primed Human Breast Tumor Epithelial Cells cDNA
library constructed into pP6, pB27, pB66 and pP6 derived from
the original pBTM116 (Vojtek and Hollenberg, 1995), pAS211
(Fromont-Racine et al., 1997) and pGADGH (Bartel et al., 1993)
plasmids, respectively.
For the LexA bait construct, we did not obtain any His+
colonies. For the Gal4 construct, 60 million clones (6-fold
the complexity of the library) were screened using the same
mating approach with HGX13 (Y187 ade2-101::loxP-kanMX-
loxP, mata) and CG1945 (mata) yeast strains. A total of 56
His+ colonies were selected from a medium lacking tryptophan,
leucine and histidine. The prey fragments of the positive clones
were amplified by PCR and sequenced at their 5′ and 3′ junctions.
The resulting sequences were used to identify the corresponding
interacting proteins in the GenBank database (NCBI) using
a fully automated procedure. A confidence score (PBS, for
Predicted Biological Score) was attributed to each interaction as
previously described (Formstecher et al., 2005).
Statistical Analysis
T-tests were performed to compare level of MTT and
incorporation [3H]TdR by cell lines challenged or not by toxins.
The differences among the cell cycle phases were assessed by
analysis of variance (ANOVA). Tukey’s Honestly Significant
Difference test was applied for comparison of means between
groups. The level of statistical significance was set at 0.05. The
tests were carried out with SPSS Statistics
R©
version 22 software
(IBM France, Bois Colombes, France).
RESULTS
SElOs Inhibits Proliferation of a Large
Number of Tumor Cell Lines But Does
Not Induce Cell Death
We first examined cell viability of 6 cell lines in the presence
of SEs using the MTT cytotoxicity assay. SEA, SEG, SEI,
FIGURE 2 | SElO inhibits cell line proliferation. Hep-2, CRL5800, CRL 1447, MDA-MB-549 SK-N-BE and PLA-OD cell lines (105 cells) were incubated with or
without SElO (0, 1, 10, 15 µg/mL) or cisplatin (10 µM) as positive control during 48 h. At the end of this incubation period, cell viability was assessed using [3H]TdR
assay for SElO only. Cell viability data are expressed as 100X ratio of value of treated cells/untreated cells. Values are mean ±SD (n = 4 independent experiments for
Hep-2, CRL1447, CRL5800, MDA-MB-549 and PLA-OD cell lines and n = 2 for SK-N-BE, each experiment containing 2 replicates). ∗P < 0.05, vs. negative control
without toxin.
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and SElN did not significantly alter cell viability of these cell
lines. Exposure to SElO surprisingly induced a dose dependent
reduction of cell viability (from 60 to 91% with 10 µg/mL), which
was statistically significant in 5 of the 6 cell lines (p < 0.05)
(Figure 1). SElM had variable effect at high concentration,
inducing proliferation of 1 of the 6 cell lines and inhibition
of proliferation in 2 of the 6 cell lines (Figure 1). We then
examined cell proliferation of 6 cell lines in the presence of
FIGURE 3 | SElO do not induce cell necrosis. Hep-2 and CRL5800 were
incubated with or without SEA, SEG, SEI, SElM, SElN, SElO (10 µg/mL) or
cisplatin (10 µM) as positive control during 48 h. At the end of this incubation
period, cell necrosis was assessed by LDH quantification in the supernatant.
The results are expressed as percentage of LDH release: % LDH
release = (value from test well – value from untreated well)/(value from lysis
solution – value from untreated well) X 100. Value and are mean ±SD. (n = 3
independent experiments, each experiment containing 3 replicates).
∗P < 0.05, vs. negative control without toxin.
SElO by measuring [3H]TdR incorporation (Figure 2). SElO
induced a dose dependent inhibition of proliferation (from 3 to
64% with 15 µg/mL) in 5 of the 6 cell lines tested (p < 0.05).
Next, we determined whether SEIO’s ability to inhibit tumor
cell proliferation could be ascribed to a cytotoxic or cytostatic
effect on the tumor cells. Thus, we examined the effect of
SEA and the egcSEs on various tumor cell lines in an LDH
assay. For these tests, we used CRL-5800 and Hep-2 as target
cells because they were reproducibly sensitive to inhibition of
proliferation by SElO. LDH values measured in supernatants
of tumor cells treated with SElO were no greater than those
of the negative controls (LDH released <5%) (Figure 3). To
determine if SElO might be inducing tumor cell apoptosis we
tested the SEIO-exposed cells in a TUNEL assay. Significant
DNA fragmentation induced by SElO at the concentrations used
in our assay (1–25 µg/mL) relative to staurosporine was not
observed (Figure 4). The absence of cell apoptosis induction
by SElO was confirmed by Annexin-V-FITC/PI staining and
caspase 3 measurement (data not shown). Hence, the inhibition
of proliferation induced by SEIO could not be ascribed to target
cell necrosis or apoptosis.
SElO Delays the Cell Cycle at the G0/G1
Phase
The inhibition of the host’ cell proliferation by SEIO in
the absence of necrosis or apoptosis could be related to the
modification of the host cell cycle by SElO. To verify this
hypothesis the cell cycle was synchronized by serum starvation.
Hep-2 cells exposed to high concentration SElO were compared
to untreated synchronized cells. The level of cell synchronization
FIGURE 4 | SElO do not induce cell apoptosis. Hep-2 cell (105 cells) were incubated in DMEM + 10% FCS for 48 h with 10 µg/mL of SElO (B), 1 µM of
staurosporine (positive control, A) or no toxin (negative control, C). Cells were fixed with paraformaldehyde (4%), permeabilised by a solution of sodium citrate and
triton X-100 before DNA 3′ end labeling by dUTP-rhodamine. Cells were seed before analysis by fluorescence microscopy with Zeiss Axiovert 135 with Axiocam
camera. Data are from 1 of 3 independent experiments that gave similar results.
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FIGURE 5 | SElO delays the cell cycle at the G0/G1 phase. Hep-2 cells (105 cells) were synchronized in G1 by serum depletion in DMEM with 0.5% FCSFCS
before being cultured during 48 h in DMEM supplemented with 5% FCS in presence or absence of 25 µg/mL SElO. After fixation and permeabilization, cells were
stained by PI. Fluorescence of the PI-stained cells was measured by flow cytometry and Mod-Fit deconvolution software that provided the estimated frequency of
cells with fractional DNA (debris, aggregate, apoptotic cells) and cells in G1, S and G2/phases of the cycles.
FIGURE 6 | Supernatant of SElO producing S. aureus induces delay in transition of G1 in S phase. Synchronized HeLa cells were exposed either to 10-fold
concentrated supernatant of S. aureus RN6390 producing SEIO, RN6390 devoid of SEIO, or DMEM. After 19 h of incubation, detached and adherent cells were
fixed in 70% ethanol overnight, stained with PI and analyzed by flow cytometry. Data were collected from 20,000 cells and analysis was performed with CFlow
software. The average percentage of cell cycle phase ± SD is indicated. The values of one representative assay out of the four is shown. Exposure of cells to the
S. aureus wild type supernatant induced a G0/G1 phase transition delay.
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was verified using flow cytometry analysis after 48 h of incubation
in serum free media: 94 ± 9% cells were in G0/G1. Analysis of
DNA contents indicated that 47 ± 4% of the cells were in S and
G2/M phases in the absence of SElO. In contrast, only 2 ± 1% of
cells were in S and G2/M phases upon exposure to SEIO for 48 h
(Figure 5). These data clearly indicate that most of the cells were
delayed in the G0/G1 phase by SElO. It is noteworthy that less
than 1% of apoptotic cells were detected during the experiments
in presence or absence of SElO, confirming that SElO did not
induce direct cell apoptosis.
Delay in G0/G1 Depends on the
Production of SEIO
Other S. aureus toxins, PSMα1 and PSMα3 and Hla, alter the cell
cycle progression and delay G2/M phase transition (Haugwitz
et al., 2006; Deplanche et al., 2015). To determine the role
of SElO compared to PSM and Hla in the alteration of the
host cell cycle by S. aureus, we compared the DNA content of
synchronized HeLa cells exposed to concentrated supernatants
of RN6390 transformed with pLUG345 or pLUG345::selo.
PSM-α1, PSM-α3 and Hla concentrations were identical in
RN6390 pLUG345 and RN6390 pLUG345::selo supernatants,
at 0.03 µg/mL, 0.05 µg/mL and 0.05 µg/mL, respectively. By
contrast, targeted proteomics analysis demonstrated the presence
of SElO in RN6390 pLUG345::selo only, at a concentration of
4.7 µg/mL.
After 19 h of exposure of the HeLa cells synchronized by the
double block thymidine to 200 µl of concentrated supernatant
of either RN6390 pLUG345 or RN6390 pLUG345::selo, a G2/M
phase transition delay was detected by cytofluorometry analysis
(Figure 6). The percentage of cells in the G2/M phase after the
treatment with RN6390 pLUG345 and RN6390 pLUG345::selo
supernatants was 45 ± 4% and 45 ± 5% respectively compared
to 19 ± 4% in control cells. The G2/M phase transition delay
corresponds to the effect of PSM-α1, PSM-α3 and Hla, detected
in supernatants of both strains.
An increase in the volume of supernatants resulted in G1/S
phase delay. Thus, after exposure of HeLa cells to 400 µl
of concentrated supernatants of RN6390 pLUG345::selo strain
producing SElO, the percentage of cells in the G1 phase was
higher (87 ± 6%) compared to untreated cells (75 ± 5%)
while only 44 ± 5% of HeLa cells exposed to 400 µl of
concentrated supernatants of RN6390 pLUG345 were in the G1
phase (Figure 6, Table 1). This proportion was stable 3 h later
since the number of cells exposed to concentrated supernatants
of SElO producing strain in the G1 phase was still higher (89± 6,
compared to untreated cells (78 ± 5%) of which 41 ± 4%
were exposed to concentrated supernatants of the control strain
(Table 1).
Yeast Two-Hybrid Analysis
We extended our analysis of cell cycle subversion by SElO
by performing a yeast-two-hybrid study using a mating assay
protocol as described in “Material and Methods.” One construct
was made with full length of the coding sequence of the mature
SElO fused C-terminal tp Gal4 DNA binding domain and
TABLE 1 | Impact of SElO production on the effect of S. aureus
supernatant on the cell cycle.
Experimental conditions G1 S G2/M
Asynchronous cells 61 ± 5% 17 ± 3% 22 ± 4%
Synchronous cells
Time after DTB release 19 h
Control 75 ± 5% 6 ± 3% 19 ± 4%
Cells + 100 µL RN6390 pLUG345::sleo 74 ± 7% 5 ± 2% 21 ± 4%
Cells + 200 µL RN6390 pLUG345::sleo 41 ± 5% 14 ± 3% 45 ± 4%
Cells + 400 µL RN6390 pLUG345::sleo 87 ± 6% 5 ± 2% 8 ± 3%
Cells + 100 µL RN6390 pLUG345 74 ± 5% 7 ± 2% 19 ± 3%
Cells + 200 µL RN6390 pLUG345 44 ± 4% 11 ± 2% 45 ± 5%
Cells + 400 µL RN6390 pLUG345 44 ± 5% 20 ± 4% 36 ± 5%
Time after DTB release 21 h
Control 78 ± 5% 12 ± 3% 10 ± 3%
Cells + 100 µL RN6390 pLUG345::sleo 84 ± 7% 5 ± 3% 11 ± 3%
Cells + 200 µL RN6390 pLUG345::sleo 69 ± 6% 9 ± 3% 22 ± 4%
Cells + 400 µL RN6390 pLUG345::sleo 89 ± 5% 8 ± 2% 3 ± 2%
Cells + 100 µL RN6390 pLUG345 87 ± 8% 6 ± 2% 7 ± 2%
Cells + 200 µL RN6390 pLUG345 85 ± 8% 6 ± 2% 9 ± 3%
Cells + 400 µL RN6390 pLUG345 41 ± 4% 20 ± 4% 39 ± 5%
After incubation, detached and adherent HeLa cells were fixed in 70% ethanol
overnight, stained with PI and analyzed by flow cytometry. Data were collected
from 20,000 cells and analysis was performed with CFlow software. The average
percentage of cell cycle phase ± SD is indicated.
tested against a human breast tumor epithelial cell library as
described. Extensive library screening identified two prey with
low confidence: a putative protein, homologue of jbug (GID
281376931) and cullin-3 (CUL3) (Supplementary Data 1 and 2).
CUL3 3 is a E3 ubiquitin ligase involved in cell cycle regulation
through cyclin E, a evolutionarily conserved protein whose
essential function is to promote the cell cycle transition from G1
to S phase.
DISCUSSION
Pathogens have developed sophisticated mechanisms which
allow them to hijack host cell functions to their own benefit.
There is a growing body of the evidence showing pathogen
induced alteration of the host cell cycle which is the major
process leading to the cellular proliferation that is required
for tissue remodeling (Nougayrède et al., 2005). Few studies
have described the capacity of S. aureus to alter the host cell
cycle. For instance, it was observed that an epidermal cell
differentiation inhibitor suppresses keratinocyte differentiation
(Sugai et al., 1992) and Hla increases the continuation of
S+G2/M phases (Haugwitz et al., 2006) while S. aureus toxin
PSM alpha induces G2/M transition delay (Deplanche et al.,
2015).
As a suitable cellular model for investigation of the
effect of S. aureus on host cell proliferation, death and
cell cycle progression, we chose a broad and diverse
group of human tumor cell lines including the epithelial
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cervix cancer HeLa cells, which are widely used as a model for
cell cycle research (Alekseeva et al., 2013; Deplanche et al., 2015).
Using recombinant enterotoxins we showed that from a group
consisting of SEA and the egcSEs, SEIO reproducibly inhibited
proliferation of the 5/6 of the cell lines tested while SElM also
inhibited 2/6 cell lines tested. Focusing on SElO, additional
experiments excluded cell death (necrosis and apoptosis) in
the observed inhibition of the proliferation. Since all toxins
were produced individually using the same S. aureus strain and
purified by the same methods, the observed differences in egcSE
cytostatic behavior reflect authentic variation in their functional
activity. At the amino acids level, percent of identity of mature
toxin tested varies from 28 to 61%; SElO shares only 31 to 40%
identity with SEA and other egcSEs, and is phylogenically distant
from the other SEs and SEls (Thomas et al., 2009). Likewise,
differences in sensitivity of the cell lines to toxins reflect intrinsic
variations in complementary receptors and activation pathways
yet to be undefined.
The investigation of DNA content in host cells synchronized
by serum starvation and exposed to SEIO clearly indicates the
arrest of host cells in G1 phase. Such arrest occurs at a different
phase of the cell cycle than that observed previously with other
S. aureus toxins (Haugwitz et al., 2006; Deplanche et al., 2015).
The ability of SElO to induce G1 arrest was confirmed by
showing that only crude supernatants of SEIO producing isogenic
S. aureus strains inhibited cell cycle progression of target cells
synchronized by the double block thymidine HeLa cells. At lower
concentration RN6390 pLUG345 and RN6390 pLUG345::selo
strains induced G2/M phase transition delay, evidenced by the
presence of PSM-α1, PSM-α3 and Hla in supernatants of both
strains.
SEIO’s ability to inhibit cell cycle progress was further
corroborated by yeast-two-hybrid studies which indicated that
Cul3 is a potential target for SEIO. Cullins are a family of
proteins that act as scaffolds conferring substrate specificity to
multimeric complexes of E3 ligases. The function of Cul3 in cell
cycle regulation is well documented (Andérica-Romero et al.,
2013). In addition to the capacity of Cul3 to regulate the entry
to mitosis, Cul3 plays a pivotal role in a degradation of cyclin E,
an evolutionarily conserved protein whose essential function is
to promote the cell cycle transition from G1 to S phase (Knoblich
et al., 1994).
The above data provides evidence that staphylococcal
enterotoxin SElO delays host cell entry into the G0/G1 phase
of the cell cycle. We identified two S. aureus toxins PSM
alpha (Deplanche et al., 2015) and SElO as cyclomodulins.
Various cyclomodulins are described in Escherichia coli such as
cytotoxic necrotizing factor, the cycle-inhibiting factor, and two
kinds of genotoxins, cytolethal distending toxins and colibactin
(Nougayrède et al., 2006). We speculate that SElO-producing
S. aureus may gain advantage in the host by arresting the cell
cycle and inducing phenotypic changes that enhance bacterial
propagation and invasion.
Comparable to other egcSEs, SElO selectively stimulates T
cells via the Vβ region of the T cell receptor (Jarraud et al., 2001;
Thomas et al., 2009) and displays an ability to induce apoptosis
in a broad panel of human tumor cells in a nitrous oxide and
cytokine dependent mechanism manner (Terman et al., 2013).
To this growing list of properties we now add SElO’s cytostatic
effect induced by cyclomodulin producing target cell alterations
that may promote S. aureus colonization. We theorize that target
tumor cells undergoing cytostasis in response to SElO may be
rendered susceptible to the cytotoxic effect of CD8+ T cells or
a constellation of tumoricidal nitrites, cytokines and perforin
granzyme known to be induced by the egcSEs and classical SEs
(Rosendahl et al., 1998). In this context, SElO was identified
together with other egcSEs in a staphylococcal supernatant used
to successfully treat 14 patients with advanced lung cancer and
pleural effusion (Ren et al., 2004; Terman et al., 2006). Notably,
several chemotherapeutics and small molecules used in cancer
treatment are cell cycle specific (Chabner and Longo, 2011).
Likewise, several non-chemotherapeutics and biologics such as
Lovastatin, methylxanthine, trifluoperazine, chloropromazine,
caffeine, sodium ascorbate and vitamin D induce alterations in
cell cycle kinetics of tumor cells and can synergize with other
agents to produce tumor cytotoxic effects (Stewart and Evans,
1989). Hence, in addition to its ability to disable host anti-
microbial defenses in its natural state, SElO acting alone or
together with other SEs or drugs may plausibly be harnessed as
an adjunct for cancer treatment.
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